ERD

4P-CAN | Personalized CANcer Primary Prevention research through Citizen Participation and digitally enabled social innovation

01-05-2023

-

30-04-2027

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

SALVOVAR | A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

01-05-2023

-

30-04-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

01-06-2023

-

31-05-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

IntReALL 2020 | International Study for Treatment of Childhood Relapsed ALL 2020

01-05-2023

-

30-04-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

Sagittarius | A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

01-07-2023

-

30-06-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

01-04-2023

-

31-03-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

LEGATO | Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study

01-06-2023

-

31-05-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

CPW | Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer.

01-05-2023

-

30-04-2027

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

01-06-2023

-

31-05-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

PIECES | TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

01-06-2023

-

31-05-2027

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

IMPACT- AML | Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

01-04-2023

-

31-03-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

LIVERATION | Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence?

01-06-2023

-

31-05-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

PREVENT | Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach

01-07-2023

-

30-06-2027

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

ONCODIR | ONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research

01-06-2023

-

30-11-2026

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

IMPORTANT | IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

01-05-2023

-

30-04-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

01-05-2023

-

30-04-2026

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-02 Strengthening research capacities of Comprehensive Cancer Infrastructures

PRIME-ROSE | PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

01-07-2023

-

30-06-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

CO-CAPTAIN | CANCER PREVENTION AMONG INDIVIDUALS WITH MENTAL ILL-HEALTH: CO-ADAPTING AND IMPLEMENTING PATIENT NAVIGATION FOR PRIMARY CANCER PREVENTION

01-06-2023

-

31-05-2026

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research

ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies

01-04-2023

-

31-03-2026

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-05 Establishing of national cancer mission hubs and creation of network to support the Mission on Cancer

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

01-05-2023

-

30-04-2028

Show more information

EU-Programme-Call

HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers

Projects overview

Selected filters:

4P-CAN | Personalized CANcer Primary Prevention research through Citizen Participation and digitally enabled social innovation

SALVOVAR | A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

IntReALL 2020 | International Study for Treatment of Childhood Relapsed ALL 2020

Sagittarius | A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

LEGATO | Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study

CPW | Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer.

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

PIECES | TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

IMPACT- AML | Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

LIVERATION | Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence?

PREVENT | Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach

ONCODIR | ONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research

IMPORTANT | IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

PRIME-ROSE | PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

CO-CAPTAIN | CANCER PREVENTION AMONG INDIVIDUALS WITH MENTAL ILL-HEALTH: CO-ADAPTING AND IMPLEMENTING PATIENT NAVIGATION FOR PRIMARY CANCER PREVENTION

ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma